Hybrid nanomaterial for stabilizing the antibiofilm activity of eugenia carryophyllata essential oil

IEEE Transactions on Nanobioscience

Volumn 11, Issue 4, 2012, Pages 360-365

  Grumezescu, Alexandru Mihai ^a   Chifiriuc, Mariana Carmen ^b   Saviuc, Crina ^b   Grumezescu, Valentina ^a   Hristu, Radu ^a   Mihaiescu, Dan Eduard ^a   Stanciu, George A ^a   Andronescu, Ecaterina ^a  

^a UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

Antibiofilm; core shell nanostructure; essential oil; Eugenia carryophyllata

Indexed keywords

ANTI-BIOFILM; BIOFILM ARCHITECTURE; BIOFILM DEVELOPMENT; BIOMEDICAL APPLICATIONS; CATHETER SURFACE; CHARACTERIZATION METHODS; CHEMICAL COMPOSITIONS; CONFOCAL LASER SCANNING MICROSCOPY; CORE/SHELL; CORE/SHELL NANOPARTICLES; EUGENIA CARRYOPHYLLATA; FUNCTIONALIZED; FUNGAL COLONIZATION; FUNGAL STRAINS; GC-MS ANALYSIS; HYBRID NANOMATERIALS; INNER SURFACES; MICROWAVE CONDITIONS; MICROWAVE-ASSISTED EXTRACTION; PRECIPITATION METHODS;

BIOFILMS; CATHETERS; COATINGS; CONFOCAL MICROSCOPY; FUNGI; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MEDICAL APPLICATIONS; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; NANOSYSTEMS; OLEIC ACID; PRECIPITATION (CHEMICAL); UNSATURATED FATTY ACIDS;

ESSENTIAL OILS;

ANTIFUNGAL AGENT; ESSENTIAL OIL; MAGNETITE NANOPARTICLE; OLEIC ACID;

ARTICLE; BIOFILM; CANDIDA; CENTRAL VENOUS CATHETER; CHEMISTRY; DRUG EFFECT; EUGENIA; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; EUGENIA; MAGNETITE NANOPARTICLES; OILS, VOLATILE; OLEIC ACID; VASCULAR ACCESS DEVICES;

EID: 84870921660     PISSN: 15361241     EISSN: None     Source Type: Journal    
DOI: 10.1109/TNB.2012.2208474     Document Type: Article

References (36)

1. S. D. Elek and P. E. Conen, "The virulence of Staphylococcus pyogenes for man. A study of the problems of wound infection," Br. J. Exp. Pathol., vol. 38, pp. 573-586, 1957.
2. E. M. Kojic and R. O. Darouiche, "Candida infections of medical devices," Clin. Microbiol. Rev., vol. 17, no. 2, pp. 255-267, 2004. (Pubitemid 38534029)
3. D. Mack, H. Rohde, and L.G. Harris et al., "Biofilm formation in medical device-related infection," Int. J. Artif. Organs, vol. 29, no. 4, pp. 343-359, 2006.
4. L. A. Mermel, B.M. Farr, and R. J. Sherertz et al., "Guidelines for the management of intravascular catheter-related infections," J. Intraven. Nurs., vol. 24, no. 3, pp. 180-205, 2001. (Pubitemid 32473356)
5. H. Koseoglu, G. Aslan, N. Esen, B. H. Sen, and H. Coban, "Ultrastructural stages of biofilm development of Escherichia Coli on urethral catheters and effects of antibiotics on biofilm formation," Urology, vol. 68, no. 5, p. 942, 2006.
6. V. D. Rosenthal, D. G. Maki, and R. Salomao et al., "Device- associated nosocomial infections in 55 intensive care units of 8 developing countries," Ann. Intern. Med., vol. 145, no. 8, pp. 582-591, 2006. (Pubitemid 46780937)
7. J. Timsit, Y. Dubois, C. Minet, A. Bonadona, M. Lugosi, C. Ara-Somohano, R. Hamidfar, and R. Schwebel, "New materials and devices for preventing biofilm associated infections," Ann. Intensive Care, vol. 34, p. 1, 2011.
8. J. Lellouche, A. Friedman, R. Lahmi, A. Gedanken, and E. Banin, "Antibiofilm surface functionalization of catheters by magnesium fluoride NP," Int. J. Nanomed., vol. 7, pp. 1175-1188, 2012.
9. R. Ogaki, M. Alexander, and P. Kingshott, "Chemical patterning in biointerface science," Mater. Today, vol. 13, no. 4, 2010.
10. M. Ahamed,M. S. AlSalhi, and M. K. J. Siddiqui, "Silver nanoparticle applications and human health," Clin. Chim. Acta, vol. 411, no. 23-24, pp. 1841-18, 2010.
11. A. Gharbi, V. Humblot, F. Turpin, C. M. Pradier, C. Imbert, and J. M. Berjeaud, "Elaboration of anti-biofilm surfaces functionalized with antifungal-cyclodextrin inclusion complexes," FEMS Immunol. Med. Microbiol., 2012, 10.1111/j.1574-695X.2012.00932.
12. J. F. Yala, P. Thebault, A. Héquet, V. Humblot, C.M. Pradier, and J. M. Berjeaud, "Elaboration of antibiofilm materials by chemical grafting of an antimicrobial peptide," Appl. Microbiol. Biotechnol., vol. 89, no. 3, pp. 623-634, 2011.
13. E. Oprea, V. Radulescu, C. Balotescu, V. Lazar, M. Bucur, P. Mladin, and I. C. Farcasanu, "Chemical and biological studies of Ribes nigrum L. buds EO," Biofactors, vol. 34, no. 1, p. 3, 2008.
14. K. Chaieb, H. Hajlaoui, T. Zmantar, A. B. Kahla-Nakni, M. Rouabhia, K. Mahbouani, and A. Barkhrouf, "The chemical composition and biological activity of clove EO, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): A short review," Phototherapy Res., vol. 21, no. 6, p. 501, 2007.
15. C. Saviuc, A.M. Grumezescu, E. Oprea, V. Radulescu, L. Dascalu, M. C. Chifiriuc, M. Bucur, O. Banu, and V. Lazar, "Antifungal activity of some vegetal extracts on Candida biofilms developed on inert substratum," Biointerface Res. Appl. Chem., vol. 1, no. 1, pp. 015-023, 2011.
16. A. S. Buteic?, D. E. Mihaiescu, A. M. Grumezescu, B. ? Vasile, A. Popescu, O. M. Mihaiescu, and R. Cristescu, "The anti-bacterial activity of magnetic nanofluid:/cephalosporins core/shell/adsorption shell proved on S. aureus and E. coli and possible applications as drug delivery systems," Dig. J. Nanomater. Biostruct., vol. 5, no. 4, p. 927, 2010.
17. C. Saviuc, A. M. Grumezescu, A. Holban, C. Bleotu, C. Chifiriuc, P. Balaure, and V. Lazar, "Phenotypical studies of raw and nanosystem embedded Eugenia carryophyllata buds EO antibacterial activity on Pseudomonas aeruginosa and Staphylococcus aureus strains," Biointerface Res. Appl. Chem., vol. 1, no. 3, pp. 111-118, 2011.
18. D. E. Mihaiescu, A. M. Grumezescu, D. E. Mogosanu, V. Traistaru, P. C. Balaure, and A. S. Buteica, "Hybrid inorganic/organic nanomaterial for controlled cephalosporins release," Biointerface Res. Appl. Chem., vol. 1, no. 2, p. 41, 2011.
19. C. Saviuc, A. M. Grumezescu, M. C. Chifiriuc, C. Bleotu, G. Stanciu, R. Hristu, D. Mihaiescu, and V. Laz?r, "In vitro methods for the study of microbial biofilms," Biointerface Res. Appl. Chem., vol. 1, no. 1, pp. 031-040, 2011.
20. A. M. Grumezescu, C. Saviuc, A. Holban, R. Hristu, C. Croitoru, G. Stanciu, C. Chifiriuc, D. Mihaiescu, P. Balaure, and V. Lazar, "Magnetic chitosan for drug targeting and in vitro drug delivery response," Biointerface Res. Appl. Chem., vol. 1, no. 5, pp. 160-165, 2011.
21. O. Banu, C. Bleotu, M. C. Chifiriuc, B. Savu, G. Stanciu, C. Antal, M. Alexandrescu, and V. Laz?r, "Virulence factors of Staphylococcus aureus and Pseudomonas aeruginosa strains involved in the etiology of cardiovascular infections," Biointerface Res. Appl. Chem., vol. 1, no. 2, p. 72, 2011.
22. R. M. Donlan, "Biofilm formation: A clinically relevant microbiological process," Clin. Infect. Dis., vol. 33, pp. 1387-1392, 2001. (Pubitemid 32955193)
23. M. R. Parsek, "Bacterial biofilms: An emerging link to disease pathogenesis," Annu. Rev. Microbiol, vol. 57, pp. 677-701, 2003. (Pubitemid 37392958)
24. N. Dror, M. Mandel, Z. Hazan, and G. Lavie, "Advances in microbial biofilm prevention on indwelling medical devices with emphasis on usage of acoustic energy," Sensors, vol. 9, pp. 2538-2554, 2009.
25. M. Ruiter, "Infusion tips: The three Rs of catheters: Reliability, resistance and ROI," ALM 2011 [Online]. Available: http://www.alnmag. com/article/infusion-tips-three-rs-catheters-reliability-resistance-and-roi
26. I. Francolini and G. Donelli, "Prevention and control of biofilm-based medical-device-related infections," FEMS Immunol. Med. Microbiol., vol. 59, no. 3, pp. 227-238, 2010.
27. P. Vergidis and R. Patel, "Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections," Infect. Dis. Clin. North Am., vol. 26, no. 1, pp. 173-186, 2012.
28. C. Sousa, C. Botelho, and R. Oliveira, "Nanotechnology applied to medical biofilms control," in Science Against Microbial Pathogens: Communicating Current Research and Technological Advances, A. Mendez-Vilas, Ed. Berlin, Germany: Springer, 2012, pp. 878-888.
29. A. M. Grumezescu, C. Saviuc, M. C. Chifiriuc, R. Hristu, D. E. G. Mihaiescu, P. Balaure, G. Stanciu, and V. Lazar, "Inhibitory activity of/usnic acid-core/shell/extra-shell nanofluid on s. aureus biofilm development," IEEE Trans. NanoBiosci., vol. 10, no. 4, pp. 269-274, 2011.
30. D. Ficai, A. Ficai, M. Alexie, M. Maganu, C. Guran, and E. Andronescu, "Amino-functionalized Fe3O4/SiO2/APTMS NP with core-shell structure as potential materials for heavy metals removal," Revista de Chimie, vol. 62, pp. 622-625, 2011.
31. F. Q. Hu, L. Wei, Z. Zhou, Y. L. Ran, Z. Li, and M. Y. Gao, Adv. Mater., vol. 18, pp. 2553-2556, 2006.
32. D.Manzu,A. Ficai, G. Voicu, B. Vasile, C. Guran, and E.Andronescu, "Polysulfone based membranes with desired pores characteristics," Materiale Plastice, vol. 47, p. 24, 2010.
33. A. M. Grumezescu, E. Andronescu, A. Ficai, C. Saviuc, D. Mihaiescu, and M. C. Chifiriuc, "Deae-Cellulose/Fe(3)O(4)/Cephalosporins hybrid materials for targeted drug delivery," Revista Romana De Materiale-Romanian J. Mater., vol. 41, no. 4, pp. 383-387, 2011.
34. E. Andronescu, M. Ficai, G. Voicu, D. Manzu, and A. Ficai, "Synthesis and characterization of collagen/hydroxyapatite-Magnetite composite material for bone cancer treatment," J. Mater. Sci. Mater. Med., vol. 21, no. 7, pp. 2237-2242, 2010.
35. M. A. Jabra-Rizk, W. A. Falkler, and T. F. Meiller, "Fungal biofilms and drug resistance," Emerging Infectious Diseases, vol. 10, no. 1, 2004.
36. J. Chandra, D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T.McCormick, and M. A. Ghannoum, J. Bacteriol., vol. 183, no. 18, p. 5385, 2011.